The Cognitive Remediation in Bipolar (CRiB) pilot study: Study protocol for a randomised controlled trial

Trials

Volumn 17, Issue 1, 2016, Pages

  Strawbridge, Rebecca ^a   Fish, Jessica ^a,b   Halari, Rozmin ^a,c   Hodsoll, John ^a   Reeder, Clare ^a   Macritchie, Karine ^a,c   McCrone, Paul ^a   Wykes, Til ^a   Young, Allan H ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b The Princess of Wales Hospital   (United Kingdom)

^c Lambeth Hospital   (United Kingdom)

Author keywords

Bipolar disorder; Cognitive remediation therapy; Randomised controlled trial; Trial protocol

Indexed keywords

ABBREVIATED SCALE OF INTELLIGENCE; ADULT; AGED; ARTICLE; BIPOLAR I DISORDER; CHILDHOOD TRAUMA QUESTIONNAIRE; CLINICAL EFFECTIVENESS; COGNITION; COGNITIVE REMEDIATION THERAPY; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED THERAPY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIGIT SYMBOL SUBSTITUTION TEST; EXECUTIVE FUNCTION; FEASIBILITY STUDY; FUNCTIONAL ASSESSMENT; GOAL ATTAINMENT; HAMILTON ANXIETY SCALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; INTELLECTUAL ASSESSMENT; INTELLIGENCE QUOTIENT; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MOOD; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PILOT STUDY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; WECHSLER ADULT INTELLIGENCE SCALE; WECHSLER MEMORY SCALE; YOUNG MANIA RATING SCALE; ADOLESCENT; BIPOLAR DISORDER; CLINICAL PROTOCOL; MIDDLE AGED; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; CLINICAL PROTOCOLS; COGNITIVE REMEDIATION; HUMANS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; YOUNG ADULT;

EID: 84979696892     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-016-1472-4     Document Type: Article

References (46)

1. Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, et al. No health without mental health. Lancet. 2007;370:859-77.
2. Young AH, Rigney U, Shaw S, Emmas C, Thompson JM. Annual cost of managing bipolar disorder to the UK healthcare system. J Affect Disord. 2011;133:450-6.
3. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiat. 2004;61:714-9.
4. Wingo AP, Harvey PD, Baldessarini RJ. Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord. 2009;11:113-25.
5. Daban C, Martinez-Aran A, Torrent C, Tabares-Seisdedos R, Balanza-Martinez V, Salazar-Fraile J, et al. Specificity of cognitive deficits in bipolar disorder versus schizophrenia: a systematic review. Psychother Psychosom. 2006;75:72-84.
6. Cella M, Reeder C, Wykes T. Lessons learnt? The importance of metacognition and its implications for cognitive remediation in schizophrenia. Frontiers in Psychol. 2015;6:1259.
7. McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiat. 2007;164:1791-802.
8. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A Meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Amer J Psychiat. 2011;168:472-85.
9. Wykes T, Spaulding WD. Thinking about the future cognitive remediation therapy-what works and could we do better? Schizophr Bull. 2011;37 Suppl 2:S80-90.
10. Anaya C, Martinez Aran A, Ayuso-Mateos JL, Wykes T, Vieta E, Scott J. A systematic review of cognitive remediation for schizo-affective and affective disorders. J Affect Disord. 2012;142:13-21.
11. Sole B, Bonnin CM, Mayoral M, Amann BL, Torres I, Gonzalez-Pinto A, et al. Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms. Eur Neuropsychopharmacol. 2015;25:257-64.
12. Torrent C, Bonnin Cdel M, Martinez-Aran A, Valle J, Amann BL, Gonzalez-Pinto A, et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiat. 2013;170:852-9.
13. Reeder C, Pile V, Crawford P, Cella M, Rose D, Wykes T, et al. The feasibility and acceptability to service users of CIRCuiTS, a computerized cognitive remediation therapy programme for schizophrenia. Behav Cogn Psychother. 2015;44(3):288-305.
14. Browne RH. On the use of a pilot sample for sample size determination. Stat Med. 1995;14:1933-40.
15. Wise T, Arnone D, Marwood L, Zahn R, Lythe KE, Young AH. Recruiting for research studies using online public advertisements: examples from research in affective disorders. Neuropsychiatr Dis Treat. 2016;12:279-85.
16. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiat. 1998;59:22-33.
17. Thompson JM, Gallagher P, Hughes JH, Watson S, Gray JM, Ferrier IN, et al. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiat. 2005;186:32-40.
18. Symonds CS, Gallagher P, Thompson JM, Young AH. Effects of the menstrual cycle on mood, neurocognitve and neuroendocrine function in healthy premenopausal women. Psychol Med. 2004;34:93-102.
19. Callard F, Broadbent M, Denis M, Hotopf M, Soncul M, Wykes T, et al. Developing a new model for patient recruitment in mental health services: a cohort study using electronic health records. BMJ Open. 2014;4:e005654.
20. Murphy C, Kelly J, Hodsoll J, Pickles A, Georgiou E, Morgan P. KCTU randomisation and IMP management system. Trials. 2013;14:P63.
21. Wechscler D. Wechsler Adult Intelligence Scale. 4th ed. Pearson: San Antonio, TX; 2010.
22. Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology. 2007;68:828-36.
23. Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiat. 2006;63:916-24.
24. Wechscler D. Wechsler Abbreviated Scale of Intelligence. 2nd ed. London: Pearson; 2011.
25. Wechsler D. Wechsler Memory Scale-(WMS-IV). New York: The Psychological Corporation; 2009.
26. Delis DC, Kaplan E, Kramer JH. Delis-Kaplan executive function system (D-KEFS). San Antonio: Psychological Corporation; 2001.
27. Manly T, Hawkins K, Evans J, Woldt K, Robertson IH. Rehabilitation of executive function: facilitation of effective goal management on complex tasks using periodic auditory alerts. Neuropsychologia. 2002;40:271-81.
28. Sullivan MJ, Edgley K, Dehoux E. A survey of multiple sclerosis. Part I: perceived cognitive problems and compensatory strategy use. Can J Rehabil. 1990;4:99-105.
29. Rosa AR, Sánchez-Moreno J, Martínez-Aran A, Salamero M, Torrent C, Reinares M, et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007;3:5.
30. Turner-Stokes L. Goal attainment scaling (GAS) in rehabilitation: a practical guide. Clin Rehabil. 2009;23:362-70.
31. Bagby RM, Parker JD, Taylor GJ. The twenty-item Toronto Alexithymia Scale-I. Item selection and cross-validation of the factor structure. J Psychosom Res. 1994;38:23-32.
32. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiat. 1960;23:56.
33. Young R, Biggs J, Ziegler V, Meyer D. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiat. 1978;133:429-35.
34. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C. The inventory for depressive symptomatology (IDS): preliminary findings. Psychiat Res. 1986;18:65-87.
35. Altman EG, Hedeker D, Peterson JL, Davis JM. The Altman self-rating mania scale. Biol Psychiat. 1997;42:948-55.
36. Rose D, Wykes T, Farrier D, Doran A-M, Sporle T, Bogner D. What do clients think of cognitive remediation therapy?: a consumer-led investigation of satisfaction and side effects. Am J Psychiat Rehabil. 2008;11:181-204.
37. Beecham J, Knapp M. Costing psychiatric interventions. In: Thornicroft G(ed). Measuring mental health needs. London: Gaskell; 2001.
38. Dolan P. The measurement of health-related quality of life for use in resource allocation decisions in health care. Handbook Health Econ. 2000;1:1723-60.
39. Wechsler D. Test of premorbid functioning. UK version (TOPF UK). Pearson Inc: Bloomington, MN; 2011.
40. Hamilton M. The assessment of anxiety states by rating. Brit J Med Psychol. 1959;32:50-5.
41. Bernstein DP, Fink L. Childhood trauma questionnaire: a retrospective self-report: manual. Orlando: Psychological Corporation; 1998.
42. First MB, Gibbon M, Spitzer RL. User's guide for the structured clinical interview for DSM-IV axis II personality disorders: SCID-II. Washington, D.C.: American Psychiatric Association; 1997.
43. Moran P, Leese M, Lee T, Walters P, Thornicroft G, Mann A. Standardised Assessment of Personality-Abbreviated Scale (SAPAS): preliminary validation of a brief screen for personality disorder. Br J Psychiat. 2003;183:228-32.
44. Roberts RD, Zeidner M & Matthews G. Does emotional intelligence meet traditional standards for an intelligence? Some new data and conclusions. Emotion. 2001;1:196-231.
45. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-9.
46. Curtis L, Burns A. Unit costs of health and social care. Kent, UK: University of Kent; 2015. www.pssru.ac.uk/project-pages/unitcosts/2015/. Accessed 21 July 2016.